NICHD - News Releases

News Releases Search Results

Your search for: AIDS/HIV, AZT, All Years All Organizations returned the following 19 results:

08/26/09		U.S. Updates Clinical Guidelines for Prevention and Treatment of Opportunistic Infections among HIV-Exposed and HIV-Infected Children
New guidelines to assist health care workers in preventing and treating the secondary infections that can afflict U.S. children exposed to, or infected with, HIV, were published by the National Institutes of Health and the Centers for Disease Control and Prevention.

05/06/09		Item of Interest: Lopinavir Proves Superior to Nevirapine in HIV-Infected Infants Who Received Single-Dose Nevirapine at Birth
A recent, scheduled interim data and safety review of a clinical study comparing anti-HIV treatment regimens based on either nevirapine (NVP) or ritonavir-boosted lopinavir (LPV/r) has found LPV/r to be more effective than NVP in HIV-infected children who received a single dose of NVP at birth.

09/10/08		Herpes Virus Changes Anti-Herpes Drug To Form That Hinders AIDS Virus
The drug acyclovir has long been used to suppress outbreaks of oral and genital herpes. Herpes viruses change acyclovir to a form that prevents them from reproducing. Now, it appears that after acyclovir is altered by herpes viruses, it also interferes with the AIDS virus’s ability to reproduce, report researchers from the National Institutes of Health and other institutions.

06/04/08		Findings Offer Insights into Role of Breastfeeding in Preventing Infant Death, HIV Infection in Resource Poor Countries
In many poor countries, mothers with HIV face a stark choice: to nurse their infants, and risk passing on HIV through their breast milk—or to formula feed, and deprive their infants of much of the natural immunity needed to protect against fatal diseases of early infancy. Now, two studies supported by the National Institutes of Health offer insights into preventing early death and HIV infection among breastfeeding infants of mothers with HIV in these countries.

02/06/08		Item of Interest: Extended Nevirapine Regimens Reduce HIV Transmission and Death in Breastfed Infants of HIV-infected Mothers
An extended course of the antiretroviral drug nevirapine (NVP) helps the breastfeeding babies of HIV-infected mothers remain HIV-negative and live longer, according to several new studies presented at the 15th Conference on Retroviruses and Opportunistic Infections held in Boston from February 3–6.

02/06/08		Item of Interest: The Post-Exposure Prophylaxis of Infant (PEPI)-Malawi Study Sponsored by NICHD and CDC
Questions and Answers

06/11/07		Public Comment: DRAFT Pediatric, Adolescent, and Maternal AIDS Branch Report to Council
Each component of the NICHD reports its activities to the National Advisory Child Health and Human Development (NACHHD) Council, the federal advisory committee for the NICHD. The NACHHD Council follows all regulations set forth in the Federal Advisory Committee Act.

01/10/07		Women's Response to Anti-HIV Therapy Improved If Treatment Begins Six Months After Earlier Preventive Regimen
A woman's response to HIV treatment with drug combinations that contain nevirapine is improved if at least six months have passed after she received the drug as a single dose during labor to prevent passing HIV on to her child. (The response to treatment is measured by the reduction of HIV in the blood.)

12/07/06		Hormonal Contraception Does Not Appear To Increase HIV Risk
Using hormonal contraception does not appear to increase women's overall risk of infection with the AIDS virus, report the authors of a large study commissioned by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.

07/09/04		Thai Study Shows That Inexpensive Treatment Reduces Risk Of Mother To Child HIV Transmission
A single dose of the drug nevirapine given at the beginning of labor, when combined with a short course of the anti-HIV drug AZT (zidovudine), dramatically reduces a woman's chances of passing HIV on to her child, according to a study of Thai women funded in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.

06/30/04		Multivitamins During Pregnancy and After Birth Delay Progression of HIV In Women
Multivitamin supplements containing high doses of the vitamin B complex, as well as vitamins C and E, given to HIV-infected women during pregnancy and for more than 5 years after they gave birth reduced the symptoms of AIDS, according to a study of Tanzanian women supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the John E. Fogarty International Center (FIC) for Advanced Study in the Health Sciences, both of the National Institutes of Health. The supplements also bolstered counts of disease-fighting immune cells, and modestly lowered HIV levels in the blood.

06/16/04		Analysis Shows Infants of Mothers Infected With HIV Face Nearly Constant Risk For HIV Infection For Duration of Breastfeeding
After four weeks of age, infants who breast feed from mothers infected with HIV continue to be at risk for infection with HIV for as long as they breastfeed, according to an analysis conducted and funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health. Previously, researchers thought the risk for being infected with the virus from breast milk diminished as an infant grew older.

06/12/02		Study Concludes Benefits of Anti-HIV Therapy During Pregnancy Outweigh Risks
A new study found no association between the use of an anti-HIV treatment that uses a combination of drugs during pregnancy and an increased risk of such birth complications as premature delivery, stillbirth, and low Apgar scores.

10/31/01		Harmless Virus Prevents HIV Variant From Spreading In Human Tissue Blocks
Human herpesvirus 6 (HHV-6), a common virus that is apparently harmless in adults, appears to prevent a form of the AIDS virus from reproducing in laboratory cultures of human tissue, according to a study published in the November issue of Nature Medicine.

07/27/01		NICHD Funds New Sites to Follow Disease Progression in HIV-Infected Women
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will fund three sites to conduct research to increase understanding of how infection with the human immunodeficiency virus (HIV) affects adolescent and adult women.

Page 1 2 >

If you are a member of the media and have questions about an NICHD news release or research, or if you would like to schedule an interview with an NICHD scientist or grantee, please contact the Public Information and Communications Branch at 301-496-5133 or by fax at 301-496-7101.